A prospective study was conducted among 100 patients selected from amongst those who were registered in the Revised national tuberculosis control programme (RNTCP) cell of VIMS Hospital Bellary from January 2012 to the end of June 2012 and they were followed up to December 2012. The purpose of the study was to evaluate the incidence of drug induced hepatotoxicity (DIH) in proved cases of pulmonary tuberculosis in patients on short term regimen of anti--tuberculosis therapy (ATT) in and around Bellary locality. To study about the predisposing factors for DIH. To study and evaluate the clinical and histopathological features of DIH. Patients above 18 years with sputum positive tuberculosis and patients coming from within and nearby areas of B...
Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis. About...
Background: Antituberculosis (ATT) drug-induced liver injury (DILI) is a common and serious adverse ...
In order to detect risk groups for drug-induced liver lesions and to develop the procedure for diffe...
Aims: To find out the frequency of hepatotoxicity in recipients of the anti-tubercular drugs, predic...
The drug-induced hepatotoxicity is a significantly increasing problem worldwide, but it is of more c...
In this study of 108 patients of new sputum positive patients 57 were males and 51 were females. The...
Objectives: To determine the hepatotoxicity in patients receiving therapy against tuberculosis, dete...
Objective: To assess the frequency of ATT induced hepatitis in pulmonary TB patients taking treatmen...
Objective: Identification of risk factors associated with anti-tuberculosis drug-induced hepatotoxic...
Objective: The aim of this study was to determine the frequency of anti-tuberculous therapy (ATT) in...
Objective: We aimed to assess and evaluate the anti-tubercular agents (ATT) induced hepatitis among ...
Background: Tuberculosis is a global pandemic which affects millions of people every year. The treat...
Tuberculosis is one of the most important communicable diseases worldwide. Its Antituberculosis ther...
Antitubercular drugs cause derangement of hepatic functions revealed by clinical examination and abn...
Objective: To determine the frequency of anti-tuberculous therapy (ATT) induced hepatitis. Methodolo...
Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis. About...
Background: Antituberculosis (ATT) drug-induced liver injury (DILI) is a common and serious adverse ...
In order to detect risk groups for drug-induced liver lesions and to develop the procedure for diffe...
Aims: To find out the frequency of hepatotoxicity in recipients of the anti-tubercular drugs, predic...
The drug-induced hepatotoxicity is a significantly increasing problem worldwide, but it is of more c...
In this study of 108 patients of new sputum positive patients 57 were males and 51 were females. The...
Objectives: To determine the hepatotoxicity in patients receiving therapy against tuberculosis, dete...
Objective: To assess the frequency of ATT induced hepatitis in pulmonary TB patients taking treatmen...
Objective: Identification of risk factors associated with anti-tuberculosis drug-induced hepatotoxic...
Objective: The aim of this study was to determine the frequency of anti-tuberculous therapy (ATT) in...
Objective: We aimed to assess and evaluate the anti-tubercular agents (ATT) induced hepatitis among ...
Background: Tuberculosis is a global pandemic which affects millions of people every year. The treat...
Tuberculosis is one of the most important communicable diseases worldwide. Its Antituberculosis ther...
Antitubercular drugs cause derangement of hepatic functions revealed by clinical examination and abn...
Objective: To determine the frequency of anti-tuberculous therapy (ATT) induced hepatitis. Methodolo...
Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis. About...
Background: Antituberculosis (ATT) drug-induced liver injury (DILI) is a common and serious adverse ...
In order to detect risk groups for drug-induced liver lesions and to develop the procedure for diffe...